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Abbreviations	  &	  Definitions	  
	  
Acquired	  immune	  deficiency	  syndrome	  (AIDS)	  –	  A	  disease	  of	  the	  immune	  system	  caused	  by	  HIV	  
infection	  
African	  National	  Congress	  (ANC)	  –	  The	  ruling	  political	  party	  in	  South	  Africa	  since	  1994	  
AIDS	  denialism	  -­‐	  An	  international	  movement	  beginning	  in	  the	  1980s	  that	  denied	  the	  link	  
between	  HIV	  and	  AIDS	  
National	  Party	  (NP)	  –	  The	  ruling	  political	  party	  in	  Apartheid-­‐era	  South	  Africa	  
Human	  immunodeficiency	  virus	  (HIV)	  –	  A	  virus	  that	  compromises	  the	  immune	  system	  and	  
eventually	  results	  in	  AIDS	  
Zidovudine	  (AZT)	  –	  An	  antiretroviral	  drug	  used	  in	  the	  treatment	  of	  HIV/AIDS	  





As	  of	  2013,	  there	  are	  more	  people	  infected	  with	  Human	  immunodeficiency	  virus	  (HIV)	  in	  sub-­‐
Saharan	  Africa	  than	  the	  rest	  of	  the	  world	  combined;	  the	  vast	  majority	  of	  whom	  reside	  in	  South	  
Africa.	  The	  contributions	  made	  by	  a	  national	  policy	  of	  Acquired	  immune	  deficiency	  syndrome	  
(AIDS)	  denialism	  have	  been	  well	  established,	  however,	  misinformation	  alone	  does	  not	  explain	  
the	  problem	  entirely.	  In	  1990,	  the	  antiretroviral	  drug	  Zidovudine	  (AZT)	  was	  approved	  for	  human	  
treatment	  and	  shown	  to	  be	  effective	  in	  reducing	  viral	  loads,	  thereby	  reducing	  the	  risk	  of	  HIV	  
transmission.	  Despite	  its	  proven	  effectiveness,	  AZT	  was	  prohibited	  throughout	  South	  Africa	  until	  
2001,	  with	  the	  notable	  exception	  of	  the	  Western	  Cape	  Province,	  which	  made	  AZT	  available	  in	  
1999.	  Using	  a	  t-­‐test	  analysis	  on	  data	  presented	  in	  the	  National	  Antenatal	  Sentinel	  HIV	  and	  
Syphilis	  Prevalence	  Survey,	  South	  Africa	  studies	  from	  1998	  to	  2011,	  I	  show	  that	  the	  percentage	  of	  
HIV	  infected	  individuals	  in	  the	  Western	  Cape	  Province	  is	  statistically	  lower	  than	  South	  Africa	  as	  a	  
whole	  (P≤	  0.0001).	  In	  addition,	  ANCOVA	  and	  regression	  analysis	  show	  values	  of	  65.33	  and	  0.935,	  
respectively,	  indicating	  a	  high	  level	  of	  covariance	  and	  correlation	  between	  the	  Western	  Cape	  
Province	  and	  national	  infection	  percentages.	  A	  P≤	  0.0001	  and	  a	  high	  correlation	  and	  covariance	  
indicate	  that	  even	  though	  the	  infection	  rates	  changed	  similarly	  (as	  would	  be	  expected	  within	  a	  
nation),	  the	  actual	  infection	  percentages	  are	  significantly	  different.	  Given	  that	  the	  Western	  Cape	  
Province	  was	  subject	  to	  the	  same	  propaganda	  and	  policies	  as	  the	  rest	  of	  South	  Africa,	  but	  
differed	  in	  the	  implementation	  of	  AZT	  and	  has	  since	  consistently	  had	  the	  lowest	  HIV	  infection	  
rate,	  it	  is	  reasonable	  to	  suggest	  that	  the	  early	  implementation	  of	  AZT	  had	  a	  profound	  effect	  on	  
infection	  rate.	  Had	  this	  program	  been	  made	  available	  nation-­‐wide,	  it	  is	  likely	  the	  AIDS	  epidemic	  
in	  South	  Africa	  would	  not	  be	  a	  disaster	  of	  the	  same	  magnitude	  that	  it	  is	  today.	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Figure	  1.	  Map	  of	  South	  Africa	  Showing	  Province	  Geography	  
	  
	  Note.	  Descriptive	  note.	  Adapted	  from	  GlobalSecurity.org	  World	  Military	  Guide.	  Copyright	  
GlobalSecurity.org	  2013.	  
	  	   	  





In	  the	  past	  two	  decades	  HIV/AIDS	  has	  been	  one	  of	  the	  greatest	  problems	  facing	  South	  
Africa,	  influencing	  everything	  in	  the	  region	  from	  everyday	  life	  to	  international	  politics.	  	  With	  1.9	  
million	  new	  infections	  in	  2008,	  sub-­‐Saharan	  Africa	  has	  the	  highest	  HIV/AIDS	  infection	  rate	  in	  the	  
world,	  accounting	  for	  67%	  of	  the	  world’s	  infected	  population	  and	  1.4	  million	  annual	  AIDS-­‐
related	  deaths	  (UNAIDS,	  2009).	  	  Within	  this	  region,	  one	  of	  the	  highest	  infection	  rates	  belongs	  to	  
South	  Africa,	  with	  11.4%	  of	  the	  population	  suffering	  from	  HIV/AIDS	  (“South	  Africa”,	  2010).	  
South	  Africa	  is	  the	  most	  developed	  nation	  in	  Africa,	  with	  a	  gross	  domestic	  product	  
separating	  it	  from	  other	  African	  nations	  by	  well	  over	  100	  billion	  dollars.	  	  Its	  economy	  is	  heavily	  
industrialized,	  its	  natural	  resources	  are	  abundant,	  and	  its	  stock	  exchange	  is	  the	  17th	  highest	  in	  
the	  world	  (“South	  Africa”,	  2010).	  	  Despite	  the	  fact	  it	  has	  many	  characteristics	  of	  a	  developed	  
nation,	  approximately	  one	  in	  ten	  individuals	  are	  infected	  with	  HIV/AIDS.	  	  In	  fact,	  no	  other	  
country	  in	  the	  world	  possesses	  both	  a	  severe	  infection	  rate	  and	  a	  developed	  economy	  (“South	  
Africa”,	  2010).	  
For	  decades,	  the	  National	  Party	  ruled	  South	  Africa	  under	  an	  apartheid	  system	  of	  
government	  –	  the	  last	  few	  years	  of	  which	  overlapped	  with	  the	  initial	  outbreak	  of	  HIV/AIDS	  in	  
the	  country.	  	  The	  response	  to	  the	  outbreak	  of	  HIV/AIDS	  in	  the	  early	  1990s	  was	  a	  poorly	  
coordinated	  effort	  aimed	  more	  at	  gaining	  good	  public	  relations	  for	  National	  Party	  leadership	  
than	  stopping	  the	  spread	  of	  HIV/AIDS	  (Heywood,	  1998).	  	  However,	  during	  the	  final	  years	  of	  
Apartheid,	  the	  HIV/AIDS	  infection	  rate	  was	  nowhere	  near	  its	  current	  level,	  and	  in	  fact	  did	  not	  
begin	  to	  reach	  pandemic	  proportions	  until	  after	  Apartheid	  had	  been	  abolished	  (“History	  of	  
HIV”,	  2010).	  	  While	  it	  can	  be	  argued	  that	  the	  massive	  infection	  rates	  of	  today	  are	  attributable	  to	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the	  National	  Party’s	  ineffectual	  response,	  the	  United	  States,	  Latin	  American	  countries,	  and	  even	  
other	  African	  nations	  experienced	  outbreaks	  of	  their	  own	  during	  the	  same	  years.	  	  In	  the	  U.S.,	  
the	  response	  to	  HIV/AIDS	  by	  both	  the	  Reagan	  and	  the	  Bush	  Administrations	  was	  lackluster	  and	  
it	  was	  not	  until	  the	  Clinton	  Administration	  that	  the	  situation	  began	  to	  improve,	  due	  primarily	  to	  
the	  various	  HIV/AIDS	  awareness	  programs	  that	  were	  implemented	  (Rimmerman,	  1998).	  	  When	  
Apartheid	  officially	  ended	  in	  1994	  with	  the	  election	  of	  Nelson	  Mandela,	  who	  was	  head	  the	  
African	  National	  Congress,	  the	  first	  serious	  HIV/AIDS	  awareness	  programs	  began	  to	  take	  shape	  
with	  the	  adoption	  of	  “South	  Africa’s	  National	  AIDS	  Plan”.	  	  However	  the	  initiative	  dissolved	  
quickly	  to	  accommodate	  the	  African	  National	  Congress’s	  vision	  of	  a	  bright,	  new	  future	  for	  South	  
Africa	  (Van	  der	  Vliet,	  2004).	  
The	  decision	  to	  focus	  on	  building	  up	  the	  nation	  and	  sweeping	  away	  the	  remnants	  of	  the	  
former	  Apartheid	  system	  took	  focus	  away	  stemming	  the	  spread	  of	  the	  HIV/AIDS	  pandemic	  at	  a	  
critical	  time	  –	  a	  decision	  that	  proved	  to	  be	  disastrous	  (“History	  of	  HIV”,	  2010).	  	  However,	  
responsibility	  for	  the	  prevalence	  of	  HIV/AIDS	  does	  not	  rest	  solely	  on	  this	  decision.	  Since	  1985,	  
antiretroviral	  therapy	  has	  been	  the	  only	  effective	  treatment	  for	  HIV/AIDS	  and	  works	  by	  
disrupting	  the	  mechanism	  of	  reproduction	  in	  retroviruses	  such	  as	  HIV.	  Had	  the	  African	  National	  
Congress	  taken	  radical	  action	  and	  created	  a	  united	  front	  against	  HIV/AIDS,	  the	  spread	  could	  at	  
least	  have	  been	  slowed	  down.	  	  Instead,	  many	  of	  the	  highest-­‐ranking	  officials	  within	  the	  African	  
National	  Congress	  repeatedly	  denied	  antiretroviral	  therapy	  to	  the	  public,	  denied	  the	  link	  
between	  HIV	  and	  AIDS,	  and	  spread	  dangerous	  misinformation	  about	  the	  disease	  at	  every	  
opportunity,	  allowing	  HIV/AIDS	  to	  run	  rampant	  in	  South	  Africa	  for	  the	  better	  part	  of	  two	  
decades	  (“History	  of	  HIV,”	  2010).	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While	  the	  propagation	  of	  misinformation	  concerning	  HIV/AIDS	  was	  no	  doubt	  extremely	  
damaging	  to	  efforts	  to	  slow	  the	  progress	  of	  the	  disease,	  the	  active	  campaigning	  against	  
antiretroviral	  therapy	  was	  the	  factor	  that	  truly	  set	  South	  Africa	  apart	  from	  the	  many	  other	  
nations	  experiencing	  the	  epidemic.	  The	  effectiveness	  of	  antiretroviral	  therapy	  in	  treating	  
HIV/AIDS	  had	  been	  well	  established	  by	  the	  early	  1990s	  in	  multiple	  studies	  worldwide	  and	  as	  a	  
result	  had	  been	  widely	  adopted	  as	  the	  only	  treatment	  to	  prevent	  HIV	  from	  developing	  into	  
AIDS.	  With	  a	  comprehensive	  plan,	  a	  national	  infection	  rate	  <5%,	  highly	  qualified	  AIDS	  specialists	  
at	  their	  disposal	  and	  knowledge	  of	  the	  course	  of	  the	  epidemic	  in	  other	  nations,	  South	  Africa	  
was	  prepared	  to	  take	  HIV/AIDS	  head	  on.	  Nevertheless,	  in	  1994,	  leading	  members	  of	  the	  African	  
National	  Congress,	  now	  fully	  in	  control	  of	  the	  nation,	  were	  openly	  questioning	  the	  validity	  of	  
the	  treatment,	  despite	  the	  approval	  of	  the	  National	  AIDS	  Plan	  by	  the	  National	  AIDS	  Committee	  
of	  South	  Africa	  (Crewe,	  2000).	  The	  refusal	  to	  allow	  the	  use	  of	  antiretroviral	  therapy	  in	  the	  
treatment	  of	  HIV/AIDS	  was	  a	  devastating	  decision	  that	  turned	  the	  promise	  of	  a	  comprehensive	  
strategy	  to	  an	  ineffectual	  one	  and	  allowed	  the	  unchecked	  proliferation	  of	  the	  virus	  for	  the	  
better	  part	  of	  a	  decade.	  
	  
Apartheid-­‐Era	  South	  Africa	  
Apartheid	  Policy	  
In	  order	  to	  better	  understand	  the	  conditions	  that	  led	  to	  the	  rapid	  rise	  of	  HIV/AIDS	  in	  
South	  Africa,	  one	  has	  to	  understand	  Apartheid	  and	  its	  impact	  on	  the	  country.	  Apartheid	  was	  a	  
form	  of	  government	  sanctioned	  racism	  and	  discrimination	  that	  lasted	  from	  1948	  until	  1994	  
under	  the	  National	  Party	  in	  South	  Africa.	  	  Under	  the	  Apartheid	  system,	  the	  South	  African	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population	  was	  classified	  into	  three	  distinct	  and	  unequal	  categories:	  White,	  Coloured,	  and	  
Black.	  	  The	  classification	  of	  race	  was	  the	  responsibility	  of	  the	  Department	  of	  Home	  Affairs.	  	  
When	  assigning	  an	  individual	  to	  a	  certain	  race,	  the	  government	  bureau	  would	  take	  into	  account	  
not	  only	  heritage	  and	  appearance,	  but	  also	  factors	  such	  as	  habits,	  education,	  speech,	  and	  
demeanor.	  	  “White”	  referred	  to	  anyone	  of	  entirely	  European	  descent.	  	  They	  enjoyed	  the	  most	  
privilege,	  comprised	  the	  ruling	  government	  and	  possessed	  a	  disproportionate	  amount	  of	  
wealth.	  	  The	  term	  “Coloured”	  designated	  any	  individual	  whose	  ancestry	  was	  not	  entirely	  white	  
(Indian,	  Asian,	  Mixed	  Race,	  etc.).	  	  The	  coloured	  sector	  of	  the	  population	  were	  given	  far	  fewer	  
rights	  than	  the	  white	  sector	  (Chokshi	  et	  al,	  1995),	  however,	  they	  enjoyed	  more	  privilege	  and	  
social	  status	  than	  the	  Black	  population.	  	  “Black”	  referred	  to	  the	  majority	  of	  the	  South	  African	  
population	  and	  designated	  anyone	  of	  native	  African	  descent.	  	  Blacks	  were	  given	  minimal	  rights,	  
were	  the	  last	  allowed	  the	  right	  to	  vote	  and,	  in	  accordance	  with	  the	  Pass	  Laws	  Act	  of	  1952,	  were	  
required	  to	  carry	  “pass	  books”	  that	  contained	  a	  photo,	  fingerprints,	  and	  personal	  information	  
to	  gain	  access	  to	  “non-­‐black”	  areas	  (Chokshi	  et	  al,	  1995).	  	  With	  the	  Population	  Registration	  Act	  
of	  1950,	  every	  South	  African	  was	  required	  to	  register	  themselves	  as	  a	  member	  of	  one	  of	  the	  
three	  races.	  Following	  the	  Separate	  Amenities	  Act	  of	  1953,	  which	  aimed	  to	  eliminate	  all	  contact	  
between	  separate	  races,	  whites	  and	  blacks	  were	  required	  to	  use	  separate	  public	  facilities,	  
transportation,	  and	  medical	  facilities.	  	  Apartheid	  legislation	  did	  not	  stop	  there,	  however	  
(Spindle	  et	  al,	  2007).	  	  The	  Mixed	  Marriages	  Act	  of	  1949	  forbade	  marriages	  between	  members	  of	  
different	  races	  and	  was	  further	  reinforced	  by	  the	  Immorality	  Act	  of	  1957	  that	  made	  illegal	  not	  
only	  relationships	  between	  different	  races,	  but	  the	  intention	  to	  pursue	  them	  as	  well	  (Spindle	  et	  
al,	  2007).	  	  In	  addition,	  the	  Suppression	  of	  Communism	  Act	  of	  1950	  made	  any	  opposition	  to	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Apartheid	  illegal	  and	  allowed	  the	  government	  to	  punish	  any	  group	  or	  individual	  they	  perceived	  
as	  a	  threat	  (Spindle	  et	  al,	  2007).	  	  
	  
HIV/AIDS	  during	  Apartheid	  
In	  1982	  the	  first	  case	  of	  HIV	  in	  South	  Africa	  was	  reported	  when	  two	  white	  homosexual	  
men	  who	  had	  recently	  travelled	  the	  United	  States	  were	  diagnosed	  (“The	  Origin,”	  2010).	  	  In	  the	  
following	  few	  years	  the	  disease	  spread	  rapidly	  within	  the	  gay	  and	  bisexual	  community	  (“The	  
Origin,”	  2010).	  Unfortunately,	  as	  the	  true	  cause	  of	  AIDS	  was	  yet	  unknown	  and	  gay	  and	  bisexual	  
individuals	  were	  a	  widely	  maligned	  part	  of	  the	  population,	  the	  National	  Party’s	  response	  was	  
almost	  non-­‐existent.	  	  The	  National	  Party’s	  ambivalent	  response	  to	  the	  outbreak	  spawned	  a	  
variety	  of	  human	  rights	  initiatives	  to	  combat	  the	  outbreak.	  	  Unfortunately	  without	  government	  
support	  of	  the	  movement	  or	  even	  recognition	  of	  the	  disease,	  the	  effectiveness	  of	  non-­‐
government	  organizations	  during	  this	  period	  was	  low.	  
Apart	  from	  the	  gay	  community,	  there	  were	  roughly	  100	  patients	  suffering	  from	  
hemophilia	  who	  contracted	  HIV	  from	  contaminated	  blood	  transfusions	  from	  1983	  to	  1985.	  	  In	  
contrast	  to	  other	  infected	  individuals,	  the	  National	  Party	  readily	  set	  up	  funds	  to	  compensate	  
the	  patients	  and	  their	  families	  for	  what	  it	  considered	  to	  be	  a	  tragic	  accident.	  	  The	  separation	  of	  
those	  with	  HIV/AIDS	  into	  those	  who	  were	  immoral	  versus	  those	  who	  were	  victims	  extended	  
even	  to	  cases	  where	  newborns	  contracted	  HIV	  from	  their	  mothers.	  	  The	  child	  was	  thought	  of	  as	  
an	  innocent,	  whereas	  the	  mother	  was	  considered	  immoral	  (Karim,	  2009).	  	  
Government	  and	  societal	  prejudice	  against	  those	  who	  were	  HIV/AIDS	  positive	  was	  not	  
only	  limited	  to	  homosexuals	  and	  those	  deemed	  immoral	  however.	  	  In	  1987	  the	  first	  black	  South	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African	  was	  diagnosed	  with	  HIV	  (Van	  der	  Vliet,	  2004)	  and	  HIV/AIDS	  began	  to	  spread	  within	  
South	  Africa’s	  black	  majority	  population.	  	  With	  this	  turn	  of	  events,	  the	  National	  Party	  labeled	  
HIV/AIDS	  as	  a	  “black	  disease”	  and	  set	  to	  rest	  any	  responsibility	  for	  implementing	  national	  
treatment	  and	  prevention	  programs	  (Karim,	  2009).	  Despite	  refusing	  to	  accept	  responsibility	  for	  
the	  epidemic	  on	  a	  nationwide	  scale,	  the	  National	  Party	  had	  created	  a	  network	  of	  AIDS	  
treatment	  centers	  with	  highly	  skilled	  medical	  professionals.	  As	  expected,	  these	  centers	  were	  
located	  in	  predominantly	  white	  areas	  and	  only	  accessible	  to	  white	  individuals	  (Crewe,	  2000).	  
Even	  with	  extreme	  government	  bias	  and	  stratified	  compensation	  for	  victims	  of	  HIV/AIDS,	  the	  
incidence	  of	  the	  disease	  remained	  relatively	  low	  for	  the	  remainder	  of	  the	  National	  Party’s	  rule	  
of	  South	  Africa	  and	  did	  not	  reach	  epidemic	  proportions	  until	  well	  after	  the	  African	  National	  
Congress	  had	  taken	  power	  (Karim,	  2009).	  	  	  
	  
The	  African	  National	  Congress	  
The	  African	  National	  Congress	  is	  South	  Africa’s	  current	  ruling	  political	  party	  and	  has	  
been	  in	  control	  of	  the	  nation	  since	  1994.	  	  The	  party	  was	  formed	  in	  1912,	  with	  the	  initial	  goal	  of	  
expanding	  the	  rights	  of	  black	  South	  Africans.	  	  However,	  when	  the	  National	  Party	  came	  to	  power	  
in	  1948	  and	  implemented	  the	  Apartheid	  system,	  the	  African	  National	  Congress	  adjusted	  its	  
focus	  nearly	  exclusively	  to	  the	  abolition	  of	  Apartheid,	  allying	  itself	  with	  other	  minority	  group	  
congresses	  (“Umzabalazo,”	  n.d.).	  	  In	  the	  late	  1940s	  and	  through	  the	  late	  1950s,	  South	  Africa	  
saw	  the	  rapid	  enactment	  of	  a	  series	  of	  racial	  restrictions	  and	  laws	  by	  the	  National	  Party	  under	  
the	  Leadership	  of	  Prime	  Minister	  Daniel	  Francois	  Malan	  (“Daniel,”	  2010).	  	  The	  majority	  of	  the	  
laws	  he	  enacted	  persisted	  until	  the	  end	  of	  Apartheid	  in	  1994	  and	  his	  actions	  during	  the	  early	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days	  of	  Apartheid	  laid	  the	  groundwork	  for	  its	  longevity	  (“Daniel,”	  2010).	  	  However	  the	  success	  
of	  Apartheid	  was	  also	  heavily	  dependent	  on	  Malan’s	  successor,	  Henrik	  Verwoerd.	  	  After	  being	  
elected	  prime	  minister	  in	  1958,	  Verwoerd	  passed	  further	  legislation	  segregating	  the	  population	  
and	  diminishing	  the	  rights	  of	  black	  South	  Africans	  (“Henrik,”	  2010).	  	  He	  was	  also	  instrumental	  in	  
transforming	  South	  Africa	  from	  a	  British	  commonwealth	  to	  a	  republic	  in	  1961,	  further	  removing	  
foreign	  influences	  (“Henrik,”	  2010).	  	  The	  comprehensive	  and	  inflexible	  legislation	  passed	  in	  less	  
than	  a	  decade	  caused	  the	  African	  National	  Congress	  to	  lose	  significant	  ground	  in	  the	  fight	  
against	  Apartheid.	  	  Amidst	  ever	  more	  pressure,	  harsh	  policies,	  and	  brutal	  acts	  by	  the	  National	  
Party,	  the	  African	  National	  Congress	  was	  banned	  and	  forced	  to	  go	  underground.	  
In	  the	  1970s,	  with	  the	  influence	  of	  the	  African	  National	  Congress	  diminished,	  the	  
National	  Party	  took	  the	  opportunity	  to	  extend	  its	  control	  over	  the	  South	  African	  population.	  	  
However	  this	  proved	  to	  be	  ineffective,	  and	  resulted	  in	  strikes	  by	  workers	  and	  protests	  by	  
thousands	  of	  students.	  	  The	  momentum	  of	  the	  African	  National	  Congress’s	  cause	  increased	  
through	  the	  1980s,	  becoming	  increasingly	  popular	  both	  domestically	  and	  abroad.	  	  This	  was	  due	  
in	  no	  small	  part	  to	  the	  actions	  of	  Oliver	  Tambo,	  who	  served	  as	  the	  president	  of	  the	  African	  
National	  Congress	  from	  1969	  to	  1991.	  	  During	  his	  leadership	  of	  the	  African	  National	  Congress,	  
the	  organization	  made	  immense	  progress	  towards	  the	  goal	  on	  an	  Apartheid-­‐free	  South	  Africa,	  
transforming	  from	  a	  fringe	  liberation	  movement	  into	  a	  contender	  for	  the	  ruling	  party	  
(“Umzabalazo,”	  n.d.).	  
It	  was	  not	  until	  1990	  when	  decades	  of	  protest,	  overwhelming	  domestic	  support,	  and	  
international	  pressures	  forced	  the	  National	  Party	  to	  repeal	  the	  ban	  on	  the	  African	  National	  
Congress.	  	  Even	  though	  the	  African	  National	  Congress	  did	  not	  officially	  come	  to	  power	  until	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1994,	  this	  marked	  the	  downfall	  of	  the	  National	  Party	  and	  the	  African	  National	  Congress’s	  
meteoric	  rise	  to	  power.	  	  In	  1991	  Nelson	  Mandela	  was	  elected	  president	  of	  the	  African	  National	  
Congress	  and	  started	  negotiations	  with	  the	  National	  Party	  that	  resulted	  in	  South	  Africa’s	  first	  
“one	  person,	  one	  vote”	  elections.	  	  In	  1994	  Nelson	  Mandela	  won	  as	  the	  African	  National	  
Congress’s	  candidate	  with	  a	  62.6%	  majority	  and	  the	  African	  National	  Congress	  has	  been	  South	  
Africa’s	  ruling	  party	  since	  (“Umzabalazo,”	  n.d.).	  	  	  	  
	  
Zidovudine	  (AZT)	  
The	  transition	  of	  power	  to	  a	  new	  political	  party	  opened	  up	  the	  possibility	  of	  change	  for	  a	  
variety	  of	  pre-­‐existing	  social	  policies,	  including	  the	  use	  of	  antiretroviral	  therapy	  to	  treat	  HIV	  
positive	  individuals.	  Zidovudine,	  also	  known	  as	  AZT,	  is	  an	  antiretroviral	  drug	  used	  primarily	  in	  
the	  treatment	  of	  HIV/AIDS.	  Originally	  intended	  as	  a	  cancer	  treatment,	  AZT	  was	  developed	  in	  
1964.	  However,	  after	  showing	  no	  significant	  results	  on	  clinical	  trials	  in	  mice,	  the	  drug	  never	  
progressed	  to	  human	  trials.	  It	  was	  not	  until	  1984,	  in	  the	  middle	  of	  the	  AIDS	  pandemic,	  that	  
clinical	  research	  on	  AZT	  resumed	  (Broder,	  2009).	  
After	  rigorous	  testing,	  AZT	  was	  found	  to	  be	  an	  effective	  inhibitor	  of	  reverse	  
transcriptase,	  the	  mechanism	  by	  which	  HIV	  replicates.	  In	  1985,	  the	  trials	  culminated	  in	  a	  
double-­‐blind,	  placebo-­‐controlled	  randomized	  trial,	  which	  definitively	  proved	  that	  AZT	  was	  safe	  
for	  human	  consumption	  and	  extended	  the	  life	  expectancy	  of	  those	  individuals	  infected	  with	  the	  
virus	  (Emmons,	  1993).	  It	  was	  not	  until	  1990	  that	  AZT	  was	  approved	  for	  infants	  and	  children	  by	  
the	  Food	  and	  Drug	  Administration	  (“AZT	  Approved”,	  1990).	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In	  the	  first	  few	  years	  following	  the	  Food	  and	  Drug	  Administration’s	  approval	  of	  AZT	  for	  
human	  use,	  the	  drug	  garnered	  controversy	  due	  to	  its	  rather	  severe	  side	  effects.	  Patients	  on	  the	  
antiretroviral	  therapy	  took	  2400	  mg	  of	  AZT	  every	  day,	  and	  would	  often	  experience	  anemia,	  
cardiomyopathy	  and	  hepatoxicity	  (“Side	  Effects”,	  2013).	  While	  the	  side	  effects	  were	  certainly	  
severe,	  the	  treatment	  was	  deemed	  acceptable,	  as	  the	  only	  alternative	  was	  to	  slowly	  die	  of	  
AIDS.	  	  
Despite	  the	  various	  studies	  that	  proved	  AZT’s	  effectiveness,	  many	  AIDS	  denialists,	  
including	  President	  Thabo	  Mbeki,	  centered	  their	  criticism	  of	  the	  treatment	  on	  the	  drug’s	  side	  
effects	  and	  used	  it	  as	  justification	  for	  refusing	  treatment.	  It	  was	  not	  until	  several	  years	  after	  
AZT’s	  unanimous	  approval,	  that	  the	  therapy	  was	  found	  to	  still	  be	  effective	  at	  a	  much	  lower	  
dosage	  (600	  mg	  per	  day),	  thereby	  greatly	  reducing	  the	  severity	  of	  the	  side	  effects.	  Currently,	  
AZT	  is	  still	  used	  as	  a	  treatment	  for	  HIV/AIDS;	  however,	  the	  drug	  is	  now	  one	  of	  three	  drugs	  
combined	  in	  a	  cocktail,	  which	  greatly	  increases	  the	  treatment	  effectiveness	  and	  hinders	  HIV’s	  
propensity	  for	  dangerous	  mutations	  (De	  Clercq,	  1994).	  
	  
The	  Early	  Response	  to	  the	  Pandemic	  
1994	  was	  a	  pivotal	  year	  for	  South	  Africa.	  The	  National	  Party	  had	  been	  supplanted	  by	  the	  
African	  National	  Congress	  and	  with	  that	  change	  came	  the	  possibility	  to	  make	  a	  new	  nation	  –	  
blessedly	  free	  of	  the	  injustices	  of	  the	  past.	  Restructuring	  of	  the	  government	  began	  on	  every	  
level,	  with	  greater	  autonomy	  than	  ever	  before	  granted	  to	  the	  provincial	  governments.	  
However,	  this	  transfer	  of	  power,	  while	  initially	  welcomed,	  proved	  to	  be	  a	  double-­‐edged	  sword	  
for	  the	  new	  nation.	  On	  one	  hand,	  the	  transfer	  of	  power	  to	  provincial	  governments	  allowed	  for	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the	  incredible	  diversity	  of	  the	  South	  African	  population	  to	  be	  better	  represented	  and	  the	  many	  
minority	  groups	  to	  have	  a	  voice,	  where	  they	  previously	  had	  none.	  On	  the	  other	  hand,	  in	  the	  
face	  of	  a	  national	  epidemic,	  the	  lack	  of	  national	  unity	  in	  implementing	  an	  effective	  plan	  against	  
HIV/AIDS	  proved	  to	  be	  extremely	  counter-­‐productive.	  
With	  a	  national	  strategy	  and	  a	  variety	  of	  non-­‐governmental	  organizations	  prepared	  to	  
show	  a	  united	  front	  against	  HIV/AIDS,	  South	  Africa	  had	  a	  real	  chance	  to	  stop	  the	  epidemic	  
before	  it	  became	  the	  catastrophe	  it	  is	  today.	  Instead,	  power	  –	  specifically	  concerning	  the	  
agency	  of	  healthcare	  administration	  –	  was	  transferred	  to	  the	  provincial	  governments;	  in	  effect,	  
there	  ceased	  to	  be	  a	  National	  AIDS	  Plan.	  In	  addition	  to	  the	  transfer	  of	  power,	  the	  National	  AIDS	  
Programme	  Director,	  who	  oversaw	  the	  implementation	  of	  the	  National	  AIDS	  Plan,	  was	  placed	  in	  
the	  Ministry	  of	  Health	  instead	  of	  the	  office	  of	  the	  president.	  Similarly,	  provincial	  governments	  
transferred	  authority	  to	  their	  own	  ministries	  of	  health	  –	  all	  of	  which	  had	  significantly	  less	  power	  
to	  coordinate	  a	  nationwide	  response	  as	  AIDS	  had	  become	  exclusively	  a	  health	  problem	  
(Nattrass,	  2008).	  While	  the	  National	  AIDS	  Plan	  still	  existed	  as	  the	  official	  policy	  of	  the	  African	  
National	  Congress,	  there	  were	  also	  nine	  other	  competing	  strategies	  at	  the	  provincial	  level	  
(Crewe,	  2000).	  A	  different	  plan	  for	  each	  province	  resulted	  in	  extreme	  disparities	  between	  the	  
responses	  of	  the	  provinces	  to	  the	  epidemic.	  	  
Another	  disastrous	  measure	  that	  hindered	  the	  nation’s	  ability	  to	  effectively	  fight	  the	  
proliferation	  of	  HIV	  was	  the	  focus	  on	  a	  prevention	  program	  as	  opposed	  to	  a	  treatment	  program	  
for	  those	  already	  infected.	  The	  decision	  was	  made	  by	  the	  Minister	  of	  Health,	  Dr.	  Nkosazana	  
Dlamini-­‐Zuma,	  who	  under	  the	  African	  National	  Congress	  administration	  had	  assumed	  full	  
control	  of	  HIV	  prevention	  in	  South	  Africa.	  Dlamini-­‐Zuma	  argued,	  against	  extreme	  opposition	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from	  health	  professionals	  and	  AIDS	  activists,	  that	  antiretroviral	  therapy	  should	  not	  be	  used	  
because	  the	  government	  wanted	  to	  focus	  on	  prevention	  of	  HIV/AIDS	  rather	  than	  treatment.	  	  In	  
1998,	  shortly	  after	  Dlamini-­‐Zuma	  made	  the	  decision	  to	  shut	  down	  a	  national	  program	  for	  AZT	  
designed	  to	  prevent	  mother-­‐to-­‐child	  transmission;	  she	  is	  quoted	  as	  saying:	  “AZT	  treatment	  will	  
have	  a	  limited	  effect	  on	  the	  epidemic,	  as	  we	  are	  treating	  individuals	  already	  infected”	  (Nattrass,	  
2008).	  This	  rationale	  indicates	  a	  severe	  misunderstanding	  in	  the	  way	  that	  HIV	  spreads	  through	  
populations.	  While	  exclusively	  preventative	  measures	  such	  as	  education	  and	  condom	  use	  are	  
certainly	  important,	  ignoring	  those	  already	  infected	  is	  an	  ineffectual	  way	  to	  prevent	  the	  spread	  
of	  the	  virus,	  since	  treatment	  of	  infected	  individuals	  substantially	  lowers	  the	  risk	  of	  transmission	  
and	  prevents	  them	  from	  spreading	  the	  virus.	  	  
	   Dlamini-­‐Zuma	  also	  cited	  cost	  of	  a	  nationwide	  antiretroviral	  therapy	  program	  as	  a	  major	  
determining	  factor	  in	  the	  decision	  to	  deny	  the	  treatment	  to	  the	  general	  population.	  It	  was	  
argued	  that	  the	  cost	  of	  testing	  every	  pregnant	  mother	  for	  HIV,	  as	  well	  as	  providing	  the	  
necessary	  counseling	  and	  care	  should	  they	  be	  found	  HIV-­‐positive,	  was	  too	  great	  for	  the	  
administration	  to	  bear.	  Nevertheless,	  medical	  and	  economic	  research	  showed	  that	  the	  cost	  of	  
testing	  and	  treatment	  pregnant	  mothers	  was	  significantly	  lower	  that	  treating	  children	  infected	  
with	  HIV	  (Nattrass,	  2008).	  
The	  true	  reasoning	  behind	  this	  decision	  to	  deny	  antiretroviral	  therapies	  to	  the	  
population	  for	  so	  long	  is	  still	  unknown;	  however	  is	  it	  likely	  that	  Dlamini-­‐Zuma	  felt	  hesitant	  to	  
make	  her	  country	  dependent	  on	  antiretroviral	  therapies,	  since	  Western	  pharmaceutical	  
companies	  produced	  the	  majority	  of	  them.	  Although,	  if	  this	  was	  the	  case,	  Dlamini-­‐Zuma	  never	  
directly	  expressed	  it	  as	  such	  and	  instead	  credited	  the	  refusal	  of	  allowing	  AZT	  to	  the	  general	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public	  to	  the	  high	  cost	  of	  the	  drug.	  After	  nearly	  50	  years	  of	  an	  oppressive	  government	  favoring	  
those	  of	  European	  descent,	  being	  at	  the	  mercy	  of	  yet	  another	  Western	  government	  would	  be	  
tantamount	  to	  economic	  imperialism,	  an	  unacceptable	  scenario	  given	  the	  African	  National	  
Congress’s	  recent	  struggle	  (Nattrass,	  2008).	   	   	  
	  
The	  Western	  Cape	  Province	  
In	  1999,	  well	  after	  the	  AIDS	  epidemic	  had	  been	  given	  years	  to	  spread	  with	  a	  national	  
infection	  rate	  of	  7%,	  the	  Western	  Cape	  Province	  decided	  to	  follow	  the	  international	  model	  and	  
provide	  AZT	  to	  HIV-­‐positive	  pregnant	  women	  (Nattrass,	  2008).	  The	  pilot	  program	  was	  based	  
upon	  a	  similar	  antenatal	  study	  performed	  in	  Uganda	  that	  showed	  a	  50%	  reduction	  in	  the	  
transmission	  of	  HIV	  from	  mother	  to	  child,	  provided	  that	  the	  mother	  was	  taking	  AZT	  (Guay,	  
1999).	  The	  decision	  to	  implement	  the	  antiretroviral	  therapy	  program	  was	  partially	  made	  due	  to	  
a	  calculation	  that	  found	  it	  was	  more	  cost-­‐effective	  to	  provide	  pregnant	  mothers	  with	  AZT	  than	  
to	  treat	  HIV-­‐positive	  babies	  with	  the	  variety	  of	  conditions	  that	  often	  result	  from	  an	  HIV	  
infection	  (Viall,	  1999).	  According	  to	  Viall	  (1999),	  “The	  cost	  of	  treating	  HIV	  -­‐infected	  women	  with	  
AZT	  in	  the	  Western	  Cape	  was	  lower	  than	  treating	  infected	  babies.	  	  Furthermore,	  the	  infant	  
mortality	  rate	  is	  elevated	  in	  the	  region	  and	  could	  increase	  up	  to	  30%	  without	  the	  AZT	  program.”	  	  	  
Although	  the	  use	  of	  AZT	  was	  banned	  throughout	  South	  Africa	  at	  the	  time,	  the	  Western	  Cape	  
Province	  was	  not	  fully	  under	  African	  National	  Congress	  control	  and	  the	  national	  decision	  to	  ban	  
antiretroviral	  therapies	  (which	  superseded	  provincial	  authority)	  did	  not	  apply,	  which	  allowed	  
the	  Western	  Cape	  to	  continue	  their	  highly	  effective	  AZT	  program	  (Viall,	  1990).	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The	  success	  of	  the	  program	  in	  turn	  convinced	  the	  provincial	  Minister	  of	  Health,	  Nick	  
Koornhof,	  to	  extend	  the	  AZT	  program	  to	  rape	  victims.	  Recognizing	  that	  rape	  victims	  are	  at	  an	  
especially	  high	  risk	  for	  contracting	  HIV,	  the	  provincial	  administration	  decided	  that	  the	  annual	  R2	  
million	  (approximately	  $218,000)	  cost	  of	  extending	  the	  program	  was	  a	  necessary	  measure	  in	  
the	  ongoing	  battle	  against	  HIV/AIDS.	  The	  program	  allocated	  R400	  (approximately	  $44)	  per	  
victim,	  which	  would	  cover	  the	  cost	  a	  four-­‐week	  course	  of	  the	  treatment	  and	  substantially	  
reduce	  the	  risk	  of	  HIV	  infection	  (Caelers,	  2000).	  
Beginning	  in	  2001,	  the	  Western	  Cape	  Department	  of	  Health	  in	  collaboration	  with	  
Doctors	  Without	  Borders	  began	  a	  program	  that	  would	  provide	  necessary	  treatment	  for	  all	  
individuals	  in	  the	  province	  infected	  with	  HIV	  (Abdullah,	  2005).	  It	  was	  not	  until	  2004	  that	  the	  
program	  had	  the	  means	  to	  begin	  providing	  treatment	  for	  the	  thousands	  of	  infected	  individuals	  
within	  the	  province.	  However,	  since	  the	  program	  has	  been	  in	  place,	  individuals	  who	  are	  at	  risk	  
for	  HIV-­‐infection	  or	  know	  that	  they	  are	  HIV-­‐positive	  can	  go	  to	  one	  of	  36	  sites	  within	  the	  
province	  where	  they	  can	  receive	  treatment.	  Unfortunately,	  antiretroviral	  therapy	  is	  not	  
available	  at	  every	  clinic	  and	  hospital	  within	  the	  province	  (Abdullah,	  2005).	  Even	  with	  the	  
limiting	  factor	  of	  the	  number	  of	  trained	  professionals	  able	  to	  provide	  the	  expertise	  the	  care	  
requires,	  the	  program	  is	  still	  by	  far	  the	  best	  in	  the	  nation.	  
	  
Methods	  
	   Given	  that	  the	  program	  employed	  by	  the	  Western	  Cape	  Province	  was	  comprehensive	  
and	  fundamentally	  only	  differed	  in	  the	  accessibility	  of	  antiretroviral	  therapy	  to	  the	  general	  
population,	  there	  must	  then	  be	  a	  significant	  difference	  between	  the	  province	  and	  the	  nation	  as	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a	  whole.	  The	  associations	  between	  the	  two	  are	  demonstrated	  through	  several	  statistical	  tests	  
using	  data	  provided	  by	  the	  South	  African	  Department	  of	  Health	  from	  1990	  until	  2011.	  Data	  for	  
each	  year	  is	  typically	  released	  in	  the	  year	  following,	  although	  the	  data	  for	  2012	  has	  not	  yet	  
been	  published.	  Three	  tests	  chosen	  to	  analyze	  the	  data,	  including	  a	  one-­‐tail	  t-­‐test,	  an	  analysis	  of	  
covariance	  and	  an	  analysis	  of	  correlation.	  The	  t-­‐test	  was	  chosen	  because	  the	  independent	  
variable	  (Western	  Cape	  or	  South	  Africa)	  was	  categorical,	  while	  the	  dependent	  variable	  
(infection	  rate)	  was	  continuous.	  In	  addition,	  it	  was	  important	  to	  exhibit	  the	  difference	  in	  mean	  
infection	  rates	  between	  the	  two	  populations.	  The	  analysis	  of	  covariance	  was	  chosen	  based	  on	  
the	  same	  grounds;	  however,	  the	  aim	  was	  to	  show	  how	  the	  variance	  in	  infection	  rates	  of	  the	  two	  
populations	  was	  linked.	  The	  analysis	  of	  correlation	  similarly	  shows	  how	  the	  change	  in	  infection	  
rates	  of	  the	  two	  populations	  are	  linked,	  but	  gives	  an	  R2	  value	  that	  is	  easier	  to	  interpret	  than	  the	  
covariance	  value.	  	  
	   One	  thing	  to	  note	  is	  that	  these	  data	  represent	  antenatal	  (before	  birth)	  data	  collected	  by	  
the	  South	  African	  Department	  of	  Health,	  and	  as	  such	  is	  not	  directly	  representative	  of	  the	  
general	  population.	  Antenatal	  data	  is	  collected	  as	  an	  alternative	  to	  infection	  rates	  for	  the	  whole	  
population	  due	  to	  both	  cost	  and	  practicality,	  since	  it	  is	  relatively	  easy	  and	  cost	  effective	  to	  test	  
women	  for	  HIV	  who	  are	  coming	  in	  for	  antenatal	  doctor	  visits.	  Nevertheless,	  estimates	  about	  the	  
HIV	  infection	  rate	  are	  made	  based	  on	  the	  antenatal	  data	  and	  can	  be	  used	  as	  a	  good	  indicator	  of	  
where	  the	  actual	  infection	  rate	  lies	  (i.e.,	  typically	  between	  one	  half	  to	  one	  third	  of	  the	  antenatal	  
value).	  A	  further	  problem	  that	  makes	  analyzing	  antenatal	  data	  the	  only	  viable	  option	  is	  that	  
while	  HIV	  infection	  rate	  data	  is	  available	  for	  the	  general	  population	  since	  1990,	  estimates	  on	  
the	  provincial	  level	  are	  not	  available	  from	  the	  Department	  of	  Health.	  Several	  studies	  have	  been	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done	  to	  map	  this	  data	  (i.e.	  The	  Demographic	  Impact	  of	  HIV/AIDS	  in	  South	  Africa.	  National	  and	  
Provincial	  Indicators	  for	  2006),	  however,	  there	  is	  no	  standard	  for	  the	  measurement	  and	  
estimation	  of	  the	  data,	  which	  increases	  the	  risk	  of	  bias	  and	  makes	  the	  data	  unsuitable	  for	  
comparison.	  	  
Results	  
In	  Figure	  1,	  the	  course	  of	  HIV	  infection	  in	  both	  the	  South	  African	  population	  and	  the	  
Western	  Cape	  population	  is	  mapped	  from	  1990	  to	  2011.	  Both	  curves	  exhibit	  a	  dramatic	  initial	  
rise	  beginning	  in	  1990	  and	  lasting	  until	  the	  early	  2000s,	  after	  which	  both	  begin	  to	  level	  off.	  The	  
R2	  values	  of	  the	  infection	  rates	  with	  respect	  to	  year	  for	  the	  Western	  Cape	  Province	  and	  South	  
Africa	  are	  0.96	  and	  0.86	  respectively,	  indicating	  in	  both	  cases	  a	  high	  correlation	  between	  
infection	  rate	  and	  year.	  One	  key	  difference	  between	  the	  two	  data	  sets	  is	  the	  infection	  rate	  as	  of	  
the	  year	  2011.	  By	  this	  time,	  both	  South	  Africa	  and	  the	  Western	  Cape	  had	  a	  fully	  implemented	  
antiretroviral	  therapy	  program	  that	  had	  been	  ongoing	  for	  several	  years,	  but	  the	  HIV	  infection	  
rate	  nationally	  was	  11.3%	  higher	  than	  in	  the	  Western	  Cape.	  
LATE	  ADOPTION	  OF	  ANTIRETROVIRAL	  THERAPY	  IN	  SOUTH	  AFRICA	  AND	  ITS	  EFFECT	  ON	  CURRENT	  HIV/AIDS	  INFECTION	  RATES	  	  
	  
21	  
Figure	  2.	  Antenatal	  HIV	  Prevalence	  in	  South	  Africa	  and	  Western	  Cape	  1990-­‐2011
	  
Note.	  Descriptive	  note.	  Adapted	  from	  the	  National	  Antenatal	  Sentinel	  HIV	  and	  Syphilis	  
Prevalence	  Survey,	  South	  Africa	  studies	  from	  1998	  to	  2011.	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   Table	  1	  provides	  the	  t-­‐test	  values	  between	  the	  antenatal	  infection	  rates	  of	  South	  Africa	  
and	  the	  Western	  Cape.	  Considering	  that	  the	  only	  fundamental	  difference	  in	  the	  two	  AIDS	  
programs	  of	  the	  nation	  and	  the	  Western	  Cape	  was	  the	  accessibility	  of	  antiretroviral	  therapy,	  
the	  mean	  difference	  if	  antiretroviral	  therapy	  had	  no	  effect	  on	  the	  outcome	  of	  infection	  rate	  
should	  be	  zero.	  However,	  the	  results	  of	  the	  t-­‐test	  strongly	  indicate	  this	  is	  not	  the	  case,	  resulting	  
in	  a	  t	  statistic	  of	  -­‐4.07,	  corresponding	  with	  a	  p	  ≤	  0.0001.	  Even	  though	  the	  general	  trend	  of	  the	  
two	  curves	  are	  similar,	  the	  infection	  rate	  values	  –	  especially	  in	  the	  later	  years	  –	  differ	  
substantially,	  resulting	  in	  a	  low	  p	  value	  and	  indicating	  that	  chance	  alone	  does	  not	  account	  for	  
the	  massive	  difference	  in	  infection	  rate	  among	  antenatal	  clinic	  patients.	  	  





Cape	   South	  Africa	  
Mean	   9.077272727	   20.15	  
Variance	   45.61422078	   117.3540476	  
Observations	   22	   22	  
Pooled	  Variance	   81.4841342	  
	  Hypothesized	  Mean	  Difference	   0	  





	  P(T<=t)	  one-­‐tail	   0.000102037	  
	  t	  Critical	  one-­‐tail	   1.681952357	  
	  	  
	   Despite	  the	  significant	  difference	  in	  mean	  values	  of	  infection	  rate,	  the	  two	  data	  sets	  
were	  expected	  to	  vary	  similarly,	  as	  they	  were	  taken	  from	  samples	  within	  the	  same	  nation.	  The	  
results	  of	  the	  analysis	  of	  covariance,	  displayed	  in	  Table	  2,	  give	  a	  value	  of	  65.33.	  The	  positive	  
covariance	  value	  indicates	  that	  the	  values	  of	  the	  two	  data	  sets	  tended	  to	  vary	  together,	  where	  
LATE	  ADOPTION	  OF	  ANTIRETROVIRAL	  THERAPY	  IN	  SOUTH	  AFRICA	  AND	  ITS	  EFFECT	  ON	  CURRENT	  HIV/AIDS	  INFECTION	  RATES	  	  
	  
23	  
high	  values	  of	  one	  corresponded	  to	  high	  values	  of	  the	  other	  (same	  for	  low	  values).	  	  However,	  
the	  magnitude	  of	  the	  covariance	  value	  is	  not	  easy	  to	  interpret,	  which	  made	  the	  analysis	  of	  
correlation	  between	  the	  data	  sets	  a	  desirable	  statistical	  test.	  The	  results	  of	  the	  analysis	  of	  
correlation	  are	  shown	  in	  Table	  3,	  and	  give	  an	  R2	  value	  of	  0.935.	  A	  perfect	  correlation	  between	  
the	  two	  data	  sets	  would	  give	  a	  value	  of	  1;	  therefore,	  a	  value	  of	  0.935	  indicates	  a	  high	  
correlation	  between	  antenatal	  infection	  rates	  in	  South	  Africa	  and	  the	  Western	  Cape.	  	  
Table	  2.	  Analysis	  of	  Covariance	  between	  Antenatal	  Infection	  Rates	  in	  South	  Africa	  and	  




Cape	   South	  Africa	  
Western	  
Cape	   0.004354085	  




Table	  3.	  Analysis	  of	  Correlation	  between	  Antenatal	  Infection	  Rates	  in	  South	  Africa	  and	  








Cape	   1	  
	  South	  Africa	   0.935432264	   1	  
	  
The	  fact	  that	  the	  two	  samples	  of	  antenatal	  infection	  rate	  had	  a	  high	  correlation	  and	  
covariance	  was	  expected,	  and	  indicate	  that	  as	  the	  national	  HIV	  infection	  rate	  increased	  so	  did	  
the	  rate	  within	  the	  Western	  Cape.	  However,	  the	  key	  difference	  between	  the	  two	  was	  the	  mean	  
difference	  in	  infection	  rate	  –	  shown	  to	  be	  statistically	  significant	  at	  a	  p	  value	  of	  ≤0.0001.	  This	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result	  strongly	  indicates	  that	  a	  factor	  beyond	  chance	  was	  responsible	  for	  the	  11.3%	  difference	  
in	  infection	  rates	  between	  South	  Africa	  and	  the	  Western	  Cape.	  	  
	  
Discussion	  
	   While	  the	  statistics	  performed	  indicate	  that	  the	  discrepancy	  in	  infection	  rate	  between	  
the	  Western	  Cape	  and	  the	  South	  African	  national	  average	  is	  significant,	  it	  is	  important	  to	  note	  
that	  lack	  of	  adoption	  of	  AZT	  is	  not	  the	  only	  factor	  that	  contributed	  to	  the	  extremely	  successful	  
proliferation	  of	  HIV.	  Beginning	  with	  the	  Mandela	  administration	  and	  lasting	  all	  the	  way	  through	  
to	  the	  current	  Zuma	  administration,	  damaging	  and	  false	  statements	  about	  the	  nature	  of	  HIV	  
and	  AIDS	  have	  been	  spread	  continuously.	  The	  failure	  to	  accept	  antiretroviral	  therapy	  as	  the	  only	  
viable	  treatment	  for	  HIV	  has	  already	  been	  thoroughly	  discussed;	  however,	  this	  was	  not	  just	  the	  
national	  policy	  of	  Dlamini-­‐Zuma.	  In	  fact,	  in	  the	  following	  administration,	  led	  by	  President	  Thabo	  
Mbeki,	  dangerous	  myths	  about	  HIV	  persisted	  (e.g.	  sex	  with	  a	  virgin	  will	  cure	  HIV,	  antiretroviral	  
therapy	  is	  poison,	  HIV	  does	  not	  cause	  AIDS	  (“AIDS	  Myths”,	  2009))	  and	  were	  more	  often	  than	  
not	  reinforced	  by	  the	  office	  of	  the	  president.	  Even	  though	  the	  national	  policy	  was	  to	  make	  
antiretroviral	  therapy	  available,	  as	  mandated	  by	  a	  court	  ruling,	  President	  Mbeki	  and	  his	  
Minister	  of	  Health,	  Manto	  Tshabalala-­‐Msimang,	  continued	  to	  deny	  the	  link	  between	  HIV	  and	  
AIDS	  and	  the	  effectiveness	  of	  antiretroviral	  therapy.	  While	  this	  dissonance	  between	  accepted	  
scientific	  knowledge	  and	  the	  African	  National	  Congress	  leadership	  may	  have	  had	  a	  less	  
damaging	  effect	  on	  the	  Western	  Cape,	  which	  had	  already	  clearly	  seen	  the	  effectiveness	  of	  
antiretroviral	  therapy	  on	  the	  HIV	  infection	  rate,	  the	  effect	  on	  the	  other	  provinces	  was	  no	  doubt	  
more	  profound.	  With	  an	  HIV	  infection	  rate	  that	  was	  continuously	  rising,	  the	  sustained	  denial	  of	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the	  truth	  about	  HIV	  in	  addition	  to	  a	  conspicuous	  lack	  of	  a	  true	  national	  plan	  to	  combat	  the	  
virus,	  it	  is	  no	  wonder	  that	  the	  disease	  has	  been	  so	  devastating.	  	  
	   In	  both	  the	  Western	  Cape	  and	  the	  nation,	  within	  a	  few	  years	  of	  the	  implementation	  of	  
antiretroviral	  therapy	  a	  distinct	  leveling	  off	  the	  HIV	  infection	  rate	  can	  be	  seen.	  One	  thing	  to	  
note	  is	  that	  the	  infection	  rate	  for	  both	  populations	  never	  experiences	  a	  sustained	  decrease,	  
even	  though	  effective	  treatment	  had	  been	  implemented	  in	  both	  cases.	  This	  is	  due	  to	  two	  
reasons:	  The	  first	  reason	  is	  a	  consequence	  of	  the	  momentum	  the	  infection	  had	  built	  up.	  Even	  
though	  antiretroviral	  therapy	  effectively	  treats	  HIV	  and	  minimizes	  the	  chances	  of	  the	  infection	  
being	  passed	  on,	  they	  do	  not	  eliminate	  it	  and	  with	  approximately	  10%	  of	  the	  nation’s	  
population	  infected,	  the	  infection	  would	  have	  continued	  to	  spread	  even	  if	  everyone	  infected	  
had	  been	  undergoing	  treatment.	  The	  second	  reason	  is	  that	  HIV	  is	  currently	  incurable	  and	  
antiretroviral	  therapy	  only	  treats	  the	  infection.	  This	  means	  that	  an	  individual	  who	  is	  placed	  on	  
antiretroviral	  therapy	  is	  still	  HIV	  positive	  and	  thus	  will	  still	  contribute	  to	  the	  infection	  rate	  (more	  
so	  than	  if	  they	  were	  not	  on	  antiretroviral	  therapy	  since	  the	  therapy	  extends	  life	  expectancy).	  
Had	  antiretroviral	  therapy	  been	  introduced	  in	  the	  early	  to	  mid-­‐1990s	  instead	  of	  the	  mid-­‐
2000s,	  the	  infection	  rate	  would	  no	  doubt	  have	  leveled	  off	  sooner	  and	  HIV	  in	  South	  Africa	  would	  
likely	  be	  a	  managed	  problem	  much	  as	  it	  is	  in	  other	  industrialized	  nations.	  The	  majority	  of	  the	  
research	  concerning	  antiretroviral	  therapy	  in	  South	  Africa	  today	  addresses	  the	  nation’s	  inability	  
to	  provide	  the	  therapy	  to	  all	  those	  who	  are	  HIV	  positive.	  Despite	  the	  nation’s	  considerable	  
resources	  and	  scientific	  minds,	  no	  viable	  solution	  has	  been	  found	  for	  this	  problem.	  The	  logistics	  
of	  testing	  a	  population	  of	  50,600,000	  for	  HIV	  and	  providing	  the	  estimated	  5,600,000	  infected	  
individuals	  with	  daily	  antiretroviral	  therapy	  is	  immense.	  With	  approximately	  10%	  of	  the	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population	  HIV	  positive,	  many	  of	  whom	  live	  in	  desperate	  poverty,	  there	  is	  no	  way	  currently	  to	  
provide	  people	  with	  the	  treatment	  and	  care	  that	  they	  require.	  While	  poverty	  would	  no	  doubt	  
have	  been	  an	  obstacle	  for	  treatment	  regardless	  of	  the	  infection	  rate,	  treating	  2%	  of	  the	  
population	  as	  opposed	  to	  10%	  would	  have	  been	  surmountable.	  
Even	  though	  antiretroviral	  therapies	  are	  currently	  available	  nationwide,	  delaying	  the	  
rollout	  until	  2004	  (on	  a	  limited	  basis	  no	  less)	  was	  too	  little	  too	  late.	  Had	  a	  comprehensive	  plan	  
with	  antiretroviral	  therapies	  been	  deployed	  in	  the	  early	  1990s	  when	  the	  African	  National	  
Congress	  first	  came	  to	  power,	  the	  infection	  could	  have	  been	  controlled	  as	  it	  was	  in	  North	  
America	  and	  Europe.	  Not	  only	  could	  the	  people	  who	  were	  infected	  have	  gotten	  treatment,	  
saving	  millions	  of	  lives,	  but	  the	  effectiveness	  of	  the	  drug	  and	  the	  legitimacy	  of	  HIV	  science	  could	  
have	  been	  demonstrated	  nationally	  far	  sooner,	  thereby	  not	  allowing	  the	  many	  dangerous	  
myths	  concerning	  HIV	  to	  take	  root	  in	  the	  nation’s	  psyche.	  	  
A	  pertinent	  question	  that	  arises	  from	  these	  results	  is	  why	  the	  leading	  politicians	  of	  the	  
African	  National	  Congress	  continually	  denied	  antiretroviral	  therapies	  to	  South	  Africa	  even	  
though	  they	  had	  repeatedly	  been	  proven	  safe	  and	  effective.	  One	  possible	  answer	  has	  already	  
been	  discussed	  by	  Nattrass,	  who	  believes	  that	  Dlamini-­‐Zuma	  and	  Thabo	  Mbeki	  considered	  the	  
acceptance	  of	  and	  dependence	  on	  antiretroviral	  therapy	  a	  form	  of	  economic	  imperialism.	  Given	  
the	  African	  National	  Congress’s	  long	  struggle	  against	  the	  Apartheid	  regime,	  this	  explanation	  
certainly	  seems	  plausible.	  However,	  what	  it	  does	  not	  take	  into	  account	  is	  that	  South	  Africa	  
could	  have	  produced	  antiretroviral	  drugs	  domestically.	  In	  1994,	  the	  infrastructure	  and	  scientific	  
expertise	  was	  already	  in	  place	  to	  provide	  that	  nation	  with	  all	  the	  AZT	  required	  to	  treat	  the	  
infected	  population	  –	  a	  number	  miniscule	  in	  comparison	  to	  what	  it	  would	  later	  become.	  The	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fact	  that	  this	  solution	  was	  not	  even	  considered	  indicates	  that	  the	  problem	  was	  more	  complex	  
than	  fear	  of	  an	  economic	  dependence.	  Refusal	  to	  produce	  the	  medication	  domestically	  may	  
have	  been	  the	  result	  of	  distrust	  of	  Western	  nations.	  After	  decades	  of	  oppression	  and	  exile	  for	  
many	  prominent	  African	  National	  Congress	  members,	  accepting	  aid	  from	  nations	  that	  had	  
allowed	  Apartheid	  to	  continue	  until	  the	  1990s	  may	  have	  been	  unacceptable.	  Unfortunately,	  this	  
is	  only	  speculation,	  as	  Thabo	  Mbeki	  and	  Dlamini-­‐Zuma	  never	  refuted	  their	  controversial	  
opinions	  on	  HIV	  and	  antiretroviral	  therapy.	  
As	  of	  2013,	  awareness	  concerning	  the	  truth	  about	  HIV	  and	  antiretroviral	  therapy	  is	  
widespread	  throughout	  South	  Africa,	  although	  there	  are	  still	  significant	  obstacles	  that	  must	  be	  
overcome.	  Misinformation	  about	  HIV	  is	  still	  prevalent	  and	  awareness	  campaigns	  have	  finally	  
begun	  to	  effectively	  address	  the	  discrepancy	  between	  scientific	  fact	  and	  common	  beliefs	  about	  
the	  virus.	  This	  increased	  scientific	  awareness	  opens	  up	  the	  possibility	  for	  groundbreaking	  new	  
treatments	  to	  combat	  HIV/AIDS;	  including	  a	  gene	  therapy	  developed	  at	  the	  Stanford	  University	  
School	  of	  Medicine,	  which	  makes	  T	  cells	  resistant	  to	  HIV	  infection	  (Richter,	  2013).	  Also,	  the	  
recent	  evidence	  from	  the	  Institute	  Pasteur	  in	  France	  indicates	  that	  early	  treatment	  with	  
antiretrovirals	  can	  functionally	  cure	  HIV	  (Gallagher,	  2013),	  which	  could	  potentially	  put	  a	  
massive	  dent	  in	  the	  HIV	  infection	  rate	  if	  treatment	  is	  successfully	  carried	  out	  nationwide.	  
However,	  given	  the	  time	  is	  has	  taken	  to	  adopt	  a	  treatment	  regimen	  that	  is	  more	  than	  two	  
decades	  old,	  it	  is	  uncertain	  whether	  or	  not	  these	  advancements	  will	  benefit	  the	  people	  of	  South	  
Africa	  in	  the	  near	  future.	  In	  addition,	  President	  Jacob	  Zuma,	  who	  in	  recent	  years	  made	  highly	  
publicized	  comments	  about	  preventing	  HIV	  infection	  by	  taking	  a	  shower,	  has	  apparently	  
reformed	  and	  is	  currently	  backing	  the	  most	  effective	  HIV	  program	  the	  nation	  has	  ever	  seen.	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Despite	  the	  many	  factors	  currently	  working	  in	  the	  nation’s	  favor,	  the	  HIV	  infection	  rate	  is	  
unlikely	  to	  decrease	  for	  many	  years	  and	  will	  continue	  to	  be	  one	  the	  most	  profound	  problems	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